Corn Futures Extend Rally on USChina Trade Optimism Scilex SCLXW Slips 214 Testing 015 Support 20260519 The Federal Reserve Is Rapidly Running Out of Reasons to Cut Interest Rates General GPACU Stalls at 1008 Breakout or Breakdown 20260515 Berkshire Hathaway Reestablishes Airline Exposure with 26 Billion Delta Air Lines Stake Is Halozyme Therapeutics HALOs 187 Correction Healthy or a Warning 20260521 Traders Price in Potential Fed Rate Hike by December After Inflation Surprise Vishay Intertechnology VSH Q1 2026 Earnings EPS Surges Past Estimates Stock Rises 5 Indian Government Confirms Adequate Fertilizer Stocks for Kharif Season AnheuserBusch InBev Shares Decline After Quarterly Sales Miss Analyst Expectations Fed Officials May Consider Rate Hikes if Inflation Remains Elevated Minutes Reveal Core Inflation Hits 32 in March as Q1 GDP Growth Disappoints at 2 amid Oil Surge Grimsbys Youth Face Challenging Job Market as One Entrepreneur Seeks Opportunity Park Medi World Shares Surge to Record High After Acquisition Update BLCO Q1 2026 Earnings EPS Surpasses Estimates by 365 Stock Declines 14 Globus Maritime Limited Q4 2025 Earnings EPS Surprises Positively with 12179 Beat Despite Revenue Not Disclosed JBS Q1 2026 Earnings EPS Miss Pressures Shares as Cost Headwinds Persist MFAO Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Higher CleanSpark CLSK Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment Balcony Solar Panels Gain Traction as US Electricity Prices Surge HOG Q1 2026 Earnings EPS Beats Estimates by 117 as Shares Rise SILO Q4 2023 Earnings Biotech Misses EPS Estimates as PreRevenue Phase Continues XELB Q1 2026 Earnings Narrowed EPS Loss Surprises Estimates Stock Surges MIDD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies EU Downgrades 2026 Growth Forecast Amid Strait of Hormuz Crisis and Energy Inflation The Hartford Q1 2026 Earnings EPS Falls Short on Underwriting Pressure UNMA Q1 2026 Earnings Solid EPS Beat Amid Quiet Revenue Picture Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues